Misplaced Pages

Iodocyanopindolol

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Drug Pharmaceutical compound
Iodocyanopindolol
Skeletal formula of iodocyanopindolol
Space-filling model of the iodocyanopindolol molecule
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • (RS)-4--2-hydroxypropoxy]-3-iodo-1H-indole-2-carbonitrile
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H20IN3O2
Molar mass413.259 g·mol
3D model (JSmol)
ChiralityRacemic mixture
SMILES
  • IC1=C(C#N)NC2=CC=CC(OCC(CNC(C)(C)C)O)=C21
InChI
  • InChI=1S/C16H20IN3O2/c1-16(2,3)19-8-10(21)9-22-13-6-4-5-11-14(13)15(17)12(7-18)20-11/h4-6,10,19-21H,8-9H2,1-3H3
  • Key:JBLUMBNIBNHRSO-UHFFFAOYSA-N
  (what is this?)  (verify)

Iodocyanopindolol (INN) is a drug related to pindolol which acts as both a β1 adrenoreceptor antagonist and a 5-HT1A receptor antagonist. Its I radiolabelled derivative has been widely used in mapping the distribution of beta adrenoreceptors in the body.

References

  1. Brodde OE, Karad K, Zerkowski HR, Rohm N, Reidemeister JC (1983). "Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding". Circulation Research. 53 (6): 752–758. doi:10.1161/01.res.53.6.752. PMID 6139182.


Beta blockers (C07)
β, non-selective
β1-selective
β2-selective
α1- + β-selective
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Serotonin receptor modulators
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7


Stub icon

This antihypertensive-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: